Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-24 @ 5:53 PM
Study NCT ID:
NCT04338568
Status:
UNKNOWN
Last Update Posted:
2020-08-17
First Post:
2020-04-04
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study
Sponsor:
Hasselt University
Organization:
Study Overview
Official Title:
Accuracy and Inter-observer Variability of Lung Ultrasound in COVID-19 Pneumonia
Status:
UNKNOWN
Status Verified Date:
2020-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SCOUT
Brief Summary:
COVID-19 is a rapidly spreading and very contagious disease caused by a novel coronavirus that can lead to respiratory insufficiency. In many patients, the chest radiograph at first presentation be normal, and early low-dose CT-scan is advocated to diagnose viral pneumonia. Lung ultrasound (LUS) has similar diagnostic properties as CT for diagnosing pneumonia. However, it has the advantage that it can be performed at point-of-care, minimizing the need to transfer the patient, reducing the number of health care personnel and equipment that come in contact with the patient and thus potentially decrease the risk of spreading the infection.
This study has the objective to examine the accuracy of lung ultrasound in patients with proven COVID-19 pneumonia.
This study has the objective to examine the accuracy of lung ultrasound in patients with proven COVID-19 pneumonia.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: